Jamjoom Pharmaceuticals Factory Company (TADAWUL:4015)
Saudi Arabia · Delayed Price · Currency is SAR 142.40
-4.20 (-2.86%)
Jul 23, 2026, 3:16 PM AST
TADAWUL:4015 Financials Overview
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 1,524 | 1,501 | 1,318 | 1,101 | 916.67 | 735.68 |
Revenue Growth | 9.63% | 13.81% | 19.77% | 20.09% | 24.60% | -8.65% |
Gross Profit Gross Profit Growth | 953.1 | 935.56 | 818.17 | 701.79 | 591.49 | 474.69 |
Operating Income Operating Income Growth | 489.31 | 475.12 | 387.82 | 315.8 | 242.46 | 185.8 |
Net Income Net Income Growth | 474.98 | 463.8 | 356.52 | 292.4 | 171.31 | 170.7 |
Earnings Per Share EPS Growth | 6.79 | 6.63 | 5.09 | 4.18 | 2.45 | 17.07 |
EPS Growth | 15.68% | 30.09% | 21.93% | 70.68% | -85.66% | -17.48% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Pharmaceutical Products Pharmaceutical Products Growth | 1,318 | 1,284 | 1,139 | 956.73 | 797.38 | 663.46 |
Consumer Health Products Consumer Health Products Growth | 206.18 | 216.77 | 179.07 | 144.09 | 119.3 | 72.22 |
Total Total Growth | 1,524 | 1,501 | 1,318 | 1,101 | 916.67 | 735.68 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 206.7 | 358.86 | 263 | 290.24 | 147.36 | 151.99 |
Total Debt Total Debt Growth | 20.77 | 16.43 | 2.09 | 2.4 | 2.64 | 1.97 |
Net Cash (Debt) Net Cash Growth | 185.93 | 342.42 | 260.91 | 287.84 | 144.72 | 150.03 |
Net Cash Growth | 37.08% | 31.24% | -9.36% | 98.89% | -3.53% | -5.55% |
Net Cash Per Share Net Cash Per Share Growth | 2.66 | 4.89 | 3.73 | 4.11 | 2.07 | 15.00 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 414.27 | 406.29 | 263.3 | 295.92 | 229.33 | 228.7 |
Capital Expenditures CapEx Growth | -51.1 | -53.04 | -56.83 | -45.18 | -86.12 | -126.79 |
Free Cash Flow Free Cash Flow Growth | 363.17 | 353.25 | 206.47 | 250.74 | 143.2 | 101.9 |
Free Cash Flow Growth | 39.25% | 71.09% | -17.66% | 75.09% | 40.52% | -10.15% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 62.52% | 62.34% | 62.05% | 63.75% | 64.53% | 64.52% |
Operating Margin | 32.10% | 31.66% | 29.41% | 28.69% | 26.45% | 25.26% |
Pretax Margin | 33.08% | 32.86% | 29.02% | 28.69% | 20.33% | 25.57% |
Profit Margin | 31.16% | 30.91% | 27.04% | 26.56% | 18.69% | 23.20% |
FCF Margin | 23.82% | 23.54% | 15.66% | 22.78% | 15.62% | 13.85% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Period Ending | Jul '26 Jul 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Dividend Per Share Dividend Per Share Growth | 4.000 | 4.000 | 3.060 | 2.500 |
Dividend Per Share Growth | 21.39% | 30.72% | 22.40% | - |
Dividend Yield | 2.81% | 2.85% | 2.08% | 2.30% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 26, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 20.99 | 21.48 | 29.88 | 27.53 | - | - |
Forward PE | - | 20.02 | 25.61 | 25.41 | - | - |
P/FCF Ratio | 27.45 | 28.20 | 51.60 | 32.10 | - | - |
PS Ratio | 6.54 | 6.64 | 8.08 | 7.31 | - | - |